(Q72556441)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

H. P. Sleeboom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135076

12 August 2023

O. L. Bijvoet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135076

12 August 2023

A. T. van Oosterom

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135076

12 August 2023

J. H. Gleed

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135076

12 August 2023

J. L. O'Riordan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135076

12 August 2023

language of work or name

English

0 references

publication date

1 July 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

30 July 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6135076

full work available at URL

12 August 2023

https://api.elsevier.com/content/article/PII:S0140673683902313?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90231-3

https://api.elsevier.com/content/article/PII:S0140673683902313?httpAccept=text/plain

12 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90231-3

12 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

239-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

New approach to the treatment of hypercalcemia The effect of short-term treatment with mithramycin

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Mithramycin treatment of hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Effect of mithramycin therapy on strontium and calcium metabolism in cancer patients (a preliminary report)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Precipitous Fall in Serum Calcium, Hypotension, and Acute Renal Failure After Intravenous Phosphate Therapy for Hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Comparison of two parenteral diphosphonates in hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Renal failure associated with intravenous diphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

A specific method for the analysis of hydroxyproline in tissues and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Development of homologous immunological assays for human parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

A carboxy-terminal specific assay for human parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Reversible defect in renal concentrating mechanism in patients with hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

The Renal Diluting and Concentrating Mechanism in Hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Effects of acute intravenous infusion of calcium chloride on the renal concentrating and diluting mechanisms in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

On the impairment of renal concentrating ability in prolonged hypercalcemia and hypercalciuria in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Renal failure during acute hypercalcaemia in patients with metastasized mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Calcium metabolism in cancer.Studies using calcium isotopes and immunoassays for parathyroid hormone and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Renal function in primary hyperparathyroidism and in non-hyperparathyroid hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Calcium clearance as a function of sodium clearance in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990231-3

7 January 2021

Mithramycin for hypercalcemia of malignant disease

4

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90231-3

12 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135076%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference